Research Article
Is Subcutaneous Route an Alternative to Intravenous Route for Mouse Contrast-Enhanced Magnetic Resonance Imaging at 1.5 T?
Table 2
Dotarem and Vasovist MRI contrast agent characteristics [
10].
| Contrast agent (trade name) | Dotarem | Vasovist |
| Molecule name | Gadoterate meglumine | Gadofosveset trisodium | Acronym | Gd-DOTA | MS-325 | Manufacturer | Guerbet | Bayer Schering | Human body region(s) approved | CNS, whole body | Vessels | Approved dose (mmol/kg) | 0.1 – 0.3 | 0.03 | Concentration | 0.5 mol/L | 0.25 mol/L | Charge | Ionic | Ionic | Molecular structure | Cyclic | Linear | Osmolality (mOsm/kg H2O at 37°C) | 1350 | 825 | Viscosity (mPa.s at 37°C) | 2.0 | 2.1 | Plasmatic relaxivities (r1/r2 1.5T in L.mmol−1.s−1) | (3.4-3.8)/(3.4-5.2) | (18-20)/(32-36) |
|
|